Realworld Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients. (PubMed, Transpl Infect Dis) - Oct 14, 2025 - "Despite the efficacy of letermovir in preventing csCMVi during immunosuppression, the occurrence of csCMVi following letermovir cessation was still a clinical concern."
Journal • Real-world evidence • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Transplantation
|
|
Atsushi Jinguji; Chika Kato; Fumihiko Ouchi; Hiroaki Shimizu; Hiroki Hatsusawa; Kairi Kojo; Kana Kato; Kaori Kondo; Masashi Shimabukuro; Noriko Doki; Riki Yamakawa; Takashi Toya; Yasutaka Masuda; Yasutaka Sadaga; Yuho Najima; Yukie Terasaki
|